Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

June 23, 2023

Study Completion Date

December 31, 2023

Conditions
Age-Related Macular DegenerationGeographic AtrophyVisual Field Defect, Central Scotoma of Both Eyes
Interventions
DIAGNOSTIC_TEST

Natural history study

Patients were monitored with a panel of visual function tests and imaging modalities. Functional tests included best-corrected visual acuity (BCVA), low-luminance visual acuity (LLVA), and contrast sensitivity function evaluation (qCSF method). Imaging assessments included fundus autofluorescence, optical coherence tomography and optical coherence tomography angiography.

Trial Locations (1)

CH-4031

University Hospital Basel, Basel

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Institute of Molecular and Clinical Ophthalmology Basel

OTHER